Ketoprofen
- TRADE NAMES: Alrheumat; Alrheumun; Aneol; Bi-Profenid; Gabrilen Retard; Keduril; Novo-Keto; Orudis (Sanofi-Aventis); Oruvail (Wyeth); Rhodis; Rhovail
- INDICATIONS: Arthritis
- CLASS: Non-steroidal anti-inflammatory (NSAID)
- HALF-LIFE: 1.5–4 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Aspirin, Caffeine, Methotrexate, Probenecid
PREGNANCY CATEGORY: C
NSAIDs may cause an increased risk of serious cardiovascular and gastrointestinal adverse events, which can be fatal. This risk may increase with duration of use.
Please login to see the rest of this drug profile
SKIN.
HAIR.
NAILS.
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
HEMATOLOGIC.
LOCAL.
NEUROMUSCULAR/SKELETAL.
OCULAR.
RENAL.
RESPIRATORY.
OTHER.
Page last updated 08/03/2022
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric
